Image de couverture de livre

Body mass index and meniscal tears: Evidence from meta‐analysis of observational studies and Mendelian randomization

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jung Hoon Lee, Seungyeop Oh, Kihun Kim, Dongjun Lee, Eunjeong Son, Tae Woo Kim, Tae Sik Goh, Noo Ree Cho, Yun Hak Kim
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Obesity Reviews
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add‐on therapy in drug‐naïve patients with type 2 diabetes ( TRIPLE ‐ AXEL study): A multicentre, randomized, 104‐week, open‐label, active‐controlled trial
par: Nam Hoon Kim, et autres
Publié: (2024)

Caution in interpreting imaging‐based rankings in network meta‐analyses of metabolic dysfunction–associated steatotic liver disease therapies
par: Seoung Hoon Kim
Publié: (2026)

Obesity Paradox in Alzheimer's Disease: A Systematic Review and Meta‐Analysis of Anthropometric Measures and Age‐Dependent Effects
par: Jeongmin Son, et autres
Publié: (2025)

Efficacy and safety of combination therapy using SGLT2 and DPP4 inhibitors to treat type 2 diabetes: An updated systematic review and meta‐analysis with focus on an Asian subpopulation
par: Myung Jin Kim, et autres
Publié: (2025)

Sex Disparities in Obesity: A Comprehensive Review of Hormonal and Genetic Influences on Obesity‐Related Phenotypes
par: Yu‐Gyeong Lee, et autres
Publié: (2025)

Front Cover
par: Ji Yoon Kim, et autres
Publié: (2026)

Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52‐week, multicentre, randomized, placebo‐controlled, phase III clinical trial
par: Eun‐Gyoung Hong, et autres
Publié: (2025)

Association between glucagon‐like peptide ‐1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database
par: Tae Hyeon Kim, et autres
Publié: (2024)

Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real‐World Observational Study
par: Jaehyun Bae, et autres
Publié: (2026)

Association Between SGLT2 Inhibitors and DPP ‐4 Inhibitors Use and Risk of Acute Pancreatitis: Findings From Nationwide Case‐Based Analyses
par: Ye‐Jee Kim, et autres
Publié: (2026)

A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
par: Soo Lim, et autres
Publié: (2024)

A 52‐week efficacy and safety study of enavogliflozin versus dapagliflozin as an add‐on to metformin in patients with type 2 diabetes mellitus: ENHANCE‐M extension study
par: Tae Seo Sohn, et autres
Publié: (2024)

Alternate‐day fasting enhanced weight loss and metabolic benefits over pair‐fed calorie restriction in obese mice
par: Hadia Nawaz, et autres
Publié: (2025)

Roux‐en‐Y Gastric Bypass Versus Single Anastomosis Duodeno–Ileal Bypass With Sleeve Gastrectomy: Different Mechanisms, Similar Outcomes
par: Hye Ju Shin, et autres
Publié: (2025)

Integration of observational and causal evidence for the association between adiposity and 17 gastrointestinal outcomes: An umbrella review and meta‐analysis
par: Min Seo Kim, et autres
Publié: (2024)

Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third‐line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP ‐4 inhibitors: A multicentre, phase 4 randomized controlled trial
par: Yun Kyung Cho, et autres
Publié: (2025)

Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
par: Sheila Pintado-Cucarella
Publié: (2016)

Long‐term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial
par: Soo Heon Kwak, et autres
Publié: (2024)

Effectiveness and Safety of Evogliptin in Patients With Type 2 Diabetes Mellitus: A Multicenter, Prospective, Observational Study
par: Jun Hwa Hong, et autres
Publié: (2026)

Maternal Pregestational and Gestational Diabetes and Neuropsychiatric Risk in Offspring: A Binational Cohort Study
par: Hyesu Jo, et autres
Publié: (2026)

Metabolic clearance rate of insulin across the glucose tolerance spectrum by race and ethnicity in youth with obesity
par: Wonhee Cho, et autres
Publié: (2025)

Exploring the value of ChatGPT in selecting antidiabetic agents for type 2 diabetes
par: Seol A. Jang, et autres
Publié: (2025)

Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial
par: Heejun Son, et autres
Publié: (2025)

Grip strength: are some adiposity phenotypes more detrimental than others? A Mendelian randomization study
par: Amy E. Taylor, et autres
Publié: (2025)

Early‐life body mass index and the risk of six cardiovascular diseases: A Mendelian Randomization study
par: Bojun Zhou, et autres
Publié: (2024)

Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
par: Inyoung Hwang, et autres
Publié: (2026)

Efficacy and safety of dapagliflozin add‐on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled study
par: In‐Kyung Jeong, et autres
Publié: (2024)

Dual add‐on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study
par: Kyung Ah Han, et autres
Publié: (2024)

Prediction of systemic exposure by food effect on a fixed‐dose combination of linagliptin and metformin extended‐release
par: Jihyun Jeon, et autres
Publié: (2025)

Waist‐to‐Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal Obesity
par: Kye‐Yeung Park, et autres
Publié: (2026)

Machine Learning Prediction of Obesity Development in Children With Overweight Using Longitudinal Body Composition Data
par: Dohyun Chun, et autres
Publié: (2026)

Serum IGF ‐1 and the Risk of Cardio‐Kidney Outcomes in Metabolic Dysfunction‐Associated Steatotic Liver Disease
par: Yongin Cho, et autres
Publié: (2026)

Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy ( EFFORT ): A 24‐week, randomized, open‐label, multicenter trial
par: So Ra Kim, et autres
Publié: (2026)

Risk Stratification of Chronic Kidney Disease in Adults Using Noninvasive Fibrosis Tests Based on the American Diabetes Association Algorithm
par: Chan‐Young Jung, et autres
Publié: (2026)

Association of Physical Activity With All‐Cause and CVD Mortality Across Metabolic and Obesity Phenotypes
par: Yunmin Han, et autres
Publié: (2026)

Gestational Diabetes Mellitus and Adverse Maternal and Neonatal Health Outcomes: an Umbrella review of Meta‐Analyses
par: Jiseung Kang, et autres
Publié: (2026)

Newer glucose‐lowering drugs and risk of suicidal ideation and behaviours: A network meta‐analysis of randomized outcome trials
par: Ying Lu, et autres
Publié: (2024)

Response to Swoap et al.
par: Gwang‐woong Go, et autres
Publié: (2025)

Integrated approach of machine learning, Mendelian randomization and experimental validation for biomarker discovery in diabetic nephropathy
par: Yidong Zhu, et autres
Publié: (2024)

Body mass index and mental disorders: A Danish cohort study
par: Sigrid Bjerge Gribsholt, et autres
Publié: (2025)